Bicocca Open Archive

Logo unimib boa
MEREGALLI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.964
EU - Europa 4.712
AS - Asia 1.649
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 18
SA - Sud America 14
AF - Africa 12
Totale 15.390
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.791
DE - Germania 988
CN - Cina 939
IT - Italia 909
SE - Svezia 812
IE - Irlanda 692
UA - Ucraina 463
HK - Hong Kong 280
GB - Regno Unito 274
CA - Canada 170
VN - Vietnam 150
AT - Austria 105
FI - Finlandia 102
RU - Federazione Russa 90
DK - Danimarca 81
FR - Francia 80
KR - Corea 62
IN - India 61
TR - Turchia 48
JP - Giappone 45
BE - Belgio 33
SG - Singapore 30
NL - Olanda 24
PL - Polonia 20
EU - Europa 18
IR - Iran 15
NZ - Nuova Zelanda 13
EG - Egitto 9
AU - Australia 8
BR - Brasile 7
ES - Italia 7
BG - Bulgaria 6
RO - Romania 6
PE - Perù 5
PT - Portogallo 5
TW - Taiwan 5
IL - Israele 4
AE - Emirati Arabi Uniti 3
GR - Grecia 3
HR - Croazia 3
IQ - Iraq 3
MX - Messico 3
RS - Serbia 3
CH - Svizzera 2
CL - Cile 2
MY - Malesia 2
SC - Seychelles 2
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EE - Estonia 1
MD - Moldavia 1
NO - Norvegia 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 15.390
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.831
Dublin 673
Chandler 666
Woodbridge 649
Frankfurt am Main 607
Wilmington 532
Jacksonville 457
Dearborn 453
Houston 406
Fairfield 405
Milan 378
New York 309
Ashburn 297
Princeton 271
Hong Kong 249
Nanjing 195
Seattle 177
Cambridge 123
Shanghai 106
Vienna 100
Beijing 77
Dong Ket 74
Lachine 74
Guangzhou 71
Lawrence 67
Nanchang 67
Boardman 65
Altamura 61
Shenyang 51
Andover 49
Jinan 40
Fremont 37
Toronto 37
Ottawa 33
Falls Church 32
San Diego 31
Tianjin 31
Brussels 30
Hangzhou 29
Pune 28
Daejeon 26
Zhengzhou 26
Changsha 25
Jiaxing 25
Kunming 25
London 23
Nürnberg 23
Helsinki 22
Los Angeles 22
Grafing 21
Norwalk 21
Sacramento 21
Hebei 20
Shangdi 20
Bergamo 19
Mountain View 17
Edmonton 16
Kocaeli 15
Leawood 15
Ningbo 15
Tokyo 15
Carate Brianza 14
Hefei 14
Kiev 14
Phoenix 13
Rome 13
Codroipo 12
Shinjuku 12
Kraków 11
Lissone 11
Taizhou 10
Mainz 9
Washington 8
Wuhan 8
Bologna 7
Chengdu 7
Monza 7
San Mateo 7
Seoul 7
Sesto San Giovanni 7
Yongin-si 7
Cagliari 6
Fuzhou 6
Huizen 6
Laurel 6
Paris 6
Pavia 6
Singapore 6
Somma Lombardo 6
Appiano Gentile 5
Clarks Summit 5
Frederick 5
Haikou 5
Induno Olona 5
Lima 5
Menlo Park 5
Merate 5
Orange 5
Redmond 5
Suwon 5
Totale 11.601
Salva come PNG Salva come JPEG
Nome #
Age-related changes in the function and structure of the peripheral sensory pathway in mice 286
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 274
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 273
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 257
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 253
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 222
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 220
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 211
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 207
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 201
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton 195
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 192
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 190
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 188
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 185
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 178
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 175
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 172
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 170
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 170
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 170
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 169
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 168
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 166
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 165
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 164
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 164
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 162
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 161
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 161
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 157
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 156
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 155
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 154
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 152
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 151
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 147
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 146
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 146
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 144
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 142
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 138
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 135
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 134
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 134
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 134
Granulocytes in actively induced Lewis rat EAE 133
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 131
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 130
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 129
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 126
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 125
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 123
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 122
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 119
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models 118
Multimodal experimental approach to the study of human neurological diseases 118
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 118
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 117
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 116
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 116
Evaluation of microtubule polimerization involved in the development of bortezomib-induced peripheral neuropathy through new in vitro and in vivo models 115
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 115
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 115
MSCs effect on Dark Agouti rats affected by chronic EAE 113
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 112
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 112
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 111
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 110
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 109
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 109
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 109
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 107
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 106
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 106
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 104
Pharmacokinetics of IVIg in Wistar rats 104
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 103
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 102
Characterization of proteasome inhibition and tubulin stabilization in an in vivo rat model of bortezomib-induced peripheral neuropathy 102
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 102
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 102
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 101
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 101
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 101
Caratterizzazione dell'effetto analgesico di un nuovo ligando del recettore I2 imidazolinico in un modello animale di dolore neuropatico indotto da bortezomib 97
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 97
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 97
Methylene blue protects against paclitaxel-induced peripheral neurotoxicity 95
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 93
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 91
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 90
Aging Action on Peripheral Nervous System in C57bl/6 Mice: a Morphological and Morphometric Study 90
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 89
“Metabolic pathways in clear cell renal cell carcinoma: possible therapeutic targets 89
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 88
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 87
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 87
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 87
Neurotoxicity induced by cisplatin, taxol and bortezomib in immunocompetent cd1 mice and immunodeficient nude mice 85
Totale 13.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.698
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019469 0 0 0 0 0 0 0 0 0 0 168 301
2019/20202.920 349 173 197 164 269 362 486 178 247 254 199 42
2020/20213.099 128 88 317 297 247 275 334 313 292 261 220 327
2021/20221.905 161 214 167 180 142 174 84 99 67 121 143 353
2022/20232.991 376 737 335 270 222 486 42 144 223 43 76 37
2023/20241.956 83 65 69 89 329 590 401 109 138 51 32 0
Totale 16.550